Nature Impact Factor 2024: 48.5 | Trend, Rankings & What Actually Gets Published

Nature's impact factor has been one of the most watched numbers in academic publishing for the past three years. The peak of 69.5 in 2022, driven by COVID-19 citation inflation, has normalized to 48.5 in 2024. For researchers deciding whether to submit, understanding why the IF moved and what the number actually measures tells you more than the headline figure.

Nature impact factor trend

The 2021 spike was almost entirely COVID-related. Nature published several landmark papers in 2020-2021 that were cited tens of thousands of times within months: structural analyses of SARS-CoV-2, vaccine mechanism papers, epidemiological modeling studies. Those citations inflated the 2021 JCR calculation, then disappeared from the 2-year window. The IF falling back to the high 40s reflects normal citation patterns, not a decline in the journal.

Nature's pre-pandemic IF was in the 42-49 range. The current 48.5 is consistent with that historical baseline.

What the impact factor means for your submission

For most submission decisions, the IF matters less than the acceptance dynamics. Nature publishes roughly 900-1,000 research articles per year from tens of thousands of submissions. The selectivity is extreme by any measure.

The IF being 48.5 vs 69.5 doesn't change your submission calculus. Nature is and has been the most prestigious general science journal in the world regardless of the specific number. What matters is whether your paper meets the editorial criteria, not where the metric lands in a given year.

What Nature editors actually look for

Nature editors are unusually explicit about their criteria. The question they ask is: does this finding change how scientists think about a fundamental problem?

Note what that question doesn't ask:

• Is this technically excellent? (Necessary but not sufficient)
• Is this novel? (Expected of all submissions, not a differentiator)
• Will this be highly cited? (Editors don't predict citations)

The specific framing matters. "We found another example of X" is not a Nature paper. "We discovered that X actually works through mechanism Y, which contradicts the prevailing model" is a Nature paper. The conceptual challenge to existing understanding is what editors are screening for at the desk stage.

Nature also has strong cross-disciplinary preferences. Papers that matter only to specialists in one narrow subfield rarely clear the desk. The finding should be legible and significant to scientists in adjacent disciplines.

Acceptance rate breakdown

Nature's headline acceptance rate is under 8%, but the distribution is heavily front-loaded:

• ~50-60% of submissions: desk rejected in 1-2 weeks
• ~15-20% of submissions: sent to external peer review
• ~8% of submissions: ultimately accepted

Desk rejection at Nature is not a judgment on the quality of the science. It's a judgment on scope. Papers are desk rejected when the editors conclude that the finding, however solid, doesn't meet the "changes how scientists think" threshold. This is the most common outcome and should be treated as useful signal: either the scope framing in the cover letter was weak, or the paper is better suited for a specialist journal.

Among papers that go to external review, the acceptance rate is roughly ~40%. If Nature is sending your paper out for review, your odds are meaningfully better than the headline number suggests.

Review timeline

Nature's review process is substantive. First revision requests regularly ask for additional experiments that could take months. Budget 2-3 months for a major revision response. Some papers go through two full revision cycles.

Types of papers Nature publishes

Nature publishes several distinct article types:

Letters (renamed "Articles" in 2019): primary research, typically 3,000 words and 5-6 figures. The flagship research format.

Articles (legacy format): longer research with extended methods. Now merged into the single "Article" format.

Brief Communications Arising: short responses to previously published Nature papers. Not a primary submission route.

Nature doesn't publish review articles in the same way specialist journals do. Research articles are the target for most authors.

The honest submission test

Before submitting to Nature, run this test on your abstract: read only the last sentence of the introduction and the first sentence of the discussion. If those two sentences together don't describe a finding that overturns or significantly revises an existing model, the paper is unlikely to clear the Nature desk.

This is not a criticism of the work. Most important science is not Nature-level science. The question is whether you're targeting the right journal.

Practical submission checklist

• [ ] Conceptual advance explicitly framed in cover letter: what changes, not what was found
• [ ] Cross-disciplinary significance is clear: scientists in adjacent fields would care
• [ ] Cover letter is one page maximum; no padding
• [ ] Data availability statement with specific repository links
• [ ] All key experiments have appropriate controls and validation
• [ ] Statistics reported completely (test, n, effect size or CI, exact p-values)
• [ ] Figures tell a coherent story with minimal reliance on supplementary
• [ ] Suggested reviewers outside your immediate specialty (given broad significance requirement)
• [ ] Competing interests and funding complete

Sources and further reading

Impact factor data from Clarivate Journal Citation Reports (released June 2025). For submission guidelines, see the Nature author instructions.

See our full Nature journal guide for editorial scope, acceptance rates, and desk rejection patterns. For manuscript preparation before you submit, see our avoid desk rejection service.

• The Lancet impact factor guide: IF 88.5, the clinical medicine benchmark
• NEJM impact factor guide: IF 78.5, for clinical research comparison
• How to choose the right journal: when Nature is the right target vs Nature Communications or PNAS
• Cover letter templates: including the high-impact journal template

How Nature's IF Has Changed Over Time

The 2021-2022 spike reflects the COVID-19 citation wave , the same pattern seen across high-IF generalist journals. Nature's IF has returned to its pre-pandemic baseline in the high 40s, which is more representative of its long-term position.

What a Nature Publication Signals vs. Other Top Journals

Nature, Science, and Cell are the three journals where a first-author paper changes your career trajectory across all scientific fields. Below that level, the signal is domain-specific: a NEJM paper matters enormously in medicine, a Nature Genetics paper matters in genetics, and so on.

For interdisciplinary researchers , those whose work touches multiple fields , Nature and Science carry more weight than any single field-specific journal because the hiring committee can immediately recognize the prestige without knowing the field's journal hierarchy. That makes Nature a particularly important target for researchers positioning themselves at disciplinary boundaries.

The Review Process: What to Expect

Desk rejection at Nature comes within 7-10 days in most cases. The editor assesses whether the paper has the scope and significance for a general audience , not whether the science is technically correct, which reviewers assess later.

Papers that make it to peer review go to 2-4 specialist reviewers whose identities are kept confidential. The revision requests at Nature are detailed and often require substantial additional experiments. The revision period can run 3-6 months. Most papers that publish in Nature go through at least one round of major revisions.

The Bottom Line

Nature at 48.5 publishes findings that change how scientists think about their field. The IF has stabilized after the COVID spike. That doesn't change the fundamental bar: the paper has to be field-defining, not just excellent. If you're genuinely in that territory, know exactly where your manuscript stands before you submit.

See also

• Science Advances Impact Factor 2026
• Nature Communications Impact Factor 2026
• Lancet Impact Factor 2026